The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Theodotou, Petros
    Chartered Certified Accountant born in October 1962
    Individual (2 offsprings)
    Officer
    2020-02-11 ~ now
    OF - Director → CIF 0
    Theodotou, Petros
    Individual (2 offsprings)
    Officer
    2020-02-11 ~ now
    OF - Secretary → CIF 0
  • 2
    Fotios Sakellaridis
    Born in September 1961
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 6
  • 1
    Androulakis, Nikistratos, Mr.
    Lawyer born in June 1984
    Individual (143 offsprings)
    Officer
    2016-11-01 ~ 2019-03-04
    OF - Director → CIF 0
  • 2
    Williams, Paul Andy, Mr.
    Admin Officer born in July 1976
    Individual (440 offsprings)
    Officer
    2012-01-30 ~ 2016-11-01
    OF - Director → CIF 0
  • 3
    Sakellaridis, Fotios, Mr.
    Businessman born in September 1961
    Individual (1 offspring)
    Officer
    2019-03-04 ~ 2020-02-11
    OF - Director → CIF 0
    Sakellaridis, Fotios, Mr.
    Individual (1 offspring)
    Officer
    2019-03-04 ~ 2020-02-11
    OF - Secretary → CIF 0
  • 4
    Enterprise House, 113-115 George Lane, London, United Kingdom
    Active Corporate (1 parent, 307 offsprings)
    Equity (Company account)
    2 GBP2024-03-31
    Officer
    2012-01-30 ~ 2016-11-01
    PE - Secretary → CIF 0
  • 5
    20-22, Wenlock Road, London, England
    Active Corporate (1 parent, 294 offsprings)
    Equity (Company account)
    1 GBP2024-09-30
    Officer
    2016-11-01 ~ 2019-03-04
    PE - Secretary → CIF 0
  • 6
    Enterprise House, 113/115 George Lane, London, United Kingdom
    Active Corporate (1 parent, 73 offsprings)
    Equity (Company account)
    2 GBP2024-03-31
    Officer
    2012-01-30 ~ 2016-11-01
    PE - Director → CIF 0
parent relation
Company in focus

THERACELL ADVANCED BIOTECHNOLOGY LTD

Standard Industrial Classification
96090 - Other Service Activities N.e.c.
Brief company account
Par Value of Share
Class 1 ordinary share
12023-02-01 ~ 2024-01-31
Fixed Assets - Investments
190,080 EUR2024-01-31
189,080 EUR2023-01-31
Debtors
2,400 EUR2024-01-31
2,150 EUR2023-01-31
Cash at bank and in hand
4,615 EUR2024-01-31
37,303 EUR2023-01-31
Current Assets
7,015 EUR2024-01-31
39,453 EUR2023-01-31
Creditors
Current
302,328 EUR2024-01-31
281,268 EUR2023-01-31
Net Current Assets/Liabilities
-295,313 EUR2024-01-31
-241,815 EUR2023-01-31
Total Assets Less Current Liabilities
-105,233 EUR2024-01-31
-52,735 EUR2023-01-31
Creditors
Non-current
30,000 EUR2024-01-31
50,000 EUR2023-01-31
Net Assets/Liabilities
-135,233 EUR2024-01-31
-102,735 EUR2023-01-31
Equity
Called up share capital
1,189 EUR2024-01-31
1,189 EUR2023-01-31
Retained earnings (accumulated losses)
-136,422 EUR2024-01-31
-103,924 EUR2023-01-31
Equity
-135,233 EUR2024-01-31
-102,735 EUR2023-01-31
Average Number of Employees
12023-02-01 ~ 2024-01-31
12022-02-01 ~ 2023-01-31
Investments in Group Undertakings
Cost valuation
190,080 EUR2024-01-31
189,080 EUR2023-01-31
Additions to investments
1,000 EUR2024-01-31
Investments in Group Undertakings
190,080 EUR2024-01-31
189,080 EUR2023-01-31
Prepayments
Current
2,400 EUR2024-01-31
2,150 EUR2023-01-31
Amounts owed to group undertakings
Current
19,600 EUR2024-01-31
25,000 EUR2023-01-31
Other Creditors
Current
4,090 EUR2024-01-31
2,150 EUR2023-01-31
Amounts owed to group undertakings
Non-current
30,000 EUR2024-01-31
50,000 EUR2023-01-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000 shares2024-01-31
Profit/Loss
Retained earnings (accumulated losses)
-32,498 EUR2023-02-01 ~ 2024-01-31

  • THERACELL ADVANCED BIOTECHNOLOGY LTD
    Info
    Registered number 07928837
    C/o Georghiades & Associates, 130a Darkes Lane, Potters Bar, Hertfordshire EN6 1AF
    Private Limited Company incorporated on 2012-01-30 (13 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-30
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.